NPORT-EX 2 BREnhancedIntlDividendTrust.HTM EX-BGY

Schedule of Investments  (unaudited) 

September 30, 2019

  

BlackRock Enhanced International Dividend Trust (BGY)

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks — 96.3%

 

Australia — 9.4%

 

Amcor PLC

    3,341,460     $ 32,157,413  

Ansell Ltd.

    642,538       11,894,271  

Sonic Healthcare Ltd.

    875,613       16,602,527  
 

 

 

 
    60,654,211  
Canada — 12.2%  

Rogers Communications, Inc., Class B

    713,351       34,745,473  

TELUS Corp.

    1,249,938       44,483,962  
 

 

 

 
    79,229,435  
Denmark — 3.0%  

Novo Nordisk A/S, Class B

    370,796       19,161,311  
 

 

 

 
Finland — 2.8%  

Kone OYJ, Class B

    315,116       17,933,367  
 

 

 

 
France — 7.3%  

Sanofi

    279,246       25,867,323  

Schneider Electric SE

    244,450       21,375,213  
 

 

 

 
    47,242,536  
Germany — 4.8%  

Deutsche Post AG, Registered Shares

    932,103       31,062,524  
 

 

 

 
India — 1.7%  

Hero MotoCorp Ltd.

    258,655       9,881,189  

Jasper Infotech Private Ltd., Series I,
(Acquired 08/08/15, cost $3,948,600)(a)(b)

    5,300       1,345,352  
 

 

 

 
    11,226,541  
Netherlands — 5.5%  

Heineken NV

    136,860       14,782,542  

Koninklijke Philips NV

    450,742       20,828,370  
 

 

 

 
    35,610,912  
Singapore — 4.5%  

DBS Group Holdings Ltd.

    829,900       15,013,810  

United Overseas Bank Ltd.

    772,900       14,364,357  
 

 

 

 
    29,378,167  
Sweden — 2.8%  

Svenska Handelsbanken AB, Class A

    1,914,788       17,912,995  
 

 

 

 
Switzerland — 11.3%  

Cie Financiere Richemont SA, Registered Shares

    122,405       8,970,531  

Nestle SA, Registered Shares

    244,451       26,511,800  

Novartis AG, Registered Shares

    302,055       26,214,431  

SGS SA, Registered Shares

    4,707       11,668,290  
 

 

 

 
    73,365,052  
Security   Shares     Value  
Taiwan — 2.1%  

Taiwan Semiconductor Manufacturing Co. Ltd.

    1,529,000     $ 13,579,857  
 

 

 

 
United Kingdom — 26.1%  

AstraZeneca PLC

    130,539       11,655,699  

BAE Systems PLC

    3,731,750       26,134,519  

British American Tobacco PLC

    840,759       31,049,416  

Diageo PLC

    328,684       13,426,833  

GlaxoSmithKline PLC

    1,596,457       34,219,400  

Imperial Brands PLC

    737,804       16,568,251  

RELX PLC

    450,469       10,710,751  

Unilever PLC

    423,786       25,470,362  
 

 

 

 
    169,235,231  
United States — 2.8%  

3M Co.(c)(d)

    108,983       17,916,805  
 

 

 

 

Total Common Stocks — 96.3%
(Cost — $616,836,302)

 

    623,508,944  
 

 

 

 

Preferred Stock

 

China — 0.6%  

Xiaoju Kuaizhi, Inc., Series A-17 (Acquired 07/28/15, cost $2,106,332),(a)(b)

    76,800       3,911,424  
 

 

 

 

Total Preferred Stocks — 0.6%
(Cost — $2,106,332)

 

    3,911,424  
 

 

 

 

Total Long-Term Investments — 96.9%
(Cost — $618,942,634)

 

    627,420,368  
 

 

 

 

Short-Term Securities — 0.9%

 

BlackRock Liquidity Funds, T-Fund, Institutional Class, 1.87%(e)(f)

    6,083,252       6,083,252  
 

 

 

 

Total Short-Term Securities — 0.9%
(Cost — $6,083,252)

 

    6,083,252  
 

 

 

 

Total Investments Before Options Written — 97.8%
(Cost — $625,025,886)

 

    633,503,620  
 

 

 

 

Options Written — (0.7)%
(Premiums Received — $5,060,905)

 

    (4,506,205
 

 

 

 

Total Investments, Net of Options Written — 97.1%
(Cost — $619,964,981)

 

    628,997,415  

Other Assets Less Liabilities — 2.9%

 

    18,563,959  
 

 

 

 

Net Assets — 100.0%

 

  $ 647,561,374  
 

 

 

 
 

 

 

        1  


Schedule of Investments  (unaudited) (continued)

September 30, 2019

  

BlackRock Enhanced International Dividend Trust (BGY)

 

 

(a) 

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(b)

Restricted security as to resale, excluding 144A securities. The Trust held restricted securities with a current value of $5,256,776, representing 0.8% of its net assets as of period end, and an original cost of $6,054,932.

(c)

All or a portion of the security has been pledged as collateral in connection with outstanding OTC derivatives.

(d) 

All or a portion of the security has been pledged and/or segregated as collateral in connection with outstanding exchange-traded options written.

(e) 

Annualized 7-day yield as of period end.

(f) 

During the period ended September 30, 2019, investments in issuers considered to be an affiliate/affiliates of the Trust for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliate    Shares
Held at
12/31/18
     Net
Activity
     Shares
Held at
09/30/19
     Value at
09/30/19
     Income      Net Realized
Gain (Loss)
 (a)
     Change in
Unrealized
Appreciation
(Depreciation)
 

BlackRock Liquidity Funds, T-Fund, Institutional Class

     25,489,943        (19,406,691      6,083,252      $ 6,083,252      $ 155,345      $      $  

 

  (a) 

Includes net capital gain distributions, if applicable.

 

For Trust compliance purposes, the Trust’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

Currency Abbreviations

AUD — Australian Dollar

CAD — Canadian Dollar

CHF — Swiss Franc

DKK — Danish Krone

EUR — Euro

GBP — British Pound

SEK — Swedish Krona

SGD — Singapore Dollar

USD — United States Dollar

Portfolio Abbreviations

OTC — Over-the-Counter

Derivative Financial Instruments Outstanding as of Period End

Exchange-Traded Options Written

 

Description    Number of
Contracts
       Expiration
Date
       Exercise
Price
       Notional
Amount (000)
       Value  
Call  

3M Co.

     238          10/11/19        USD     175.00        USD     3,913        $ (1,904

3M Co.

     164          10/18/19        USD     167.50        USD     2,696          (33,046

Rogers Communications, Inc., Class B

     996          10/18/19        CAD     70.00        CAD     6,427          (4,511

3M Co.

     88          10/25/19        USD     172.50        USD     1,447          (15,092

Rogers Communications, Inc., Class B

     1,025          11/15/19        CAD     70.00        CAD     701          (14,700
                          

 

 

 
                           $ (69,253
                          

 

 

 

 

 

2      


Schedule of Investments  (unaudited) (continued)

September 30, 2019

  

BlackRock Enhanced International Dividend Trust (BGY)

 

OTC Options Written

 

Description    Counterparty    Number of
Contracts
     Expiration
Date
     Exercise
Price
     Notional
Amount (000)
     Value  
Call       

TELUS Corp.

   Citibank N.A.      68,800        10/01/19      CAD     47.16      CAD     3,242      $ (6,834

Imperial Brands PLC

   UBS AG      38,400        11/01/19      GBP     22.23      GBP     701        (584

Svenska Handelsbanken AB, Class A

   Morgan Stanley & Co. International PLC      125,400        10/03/19      SEK     85.82      SEK     11,548        (80,041

Taiwan Semiconductor Manufacturing Co. Ltd.

   Morgan Stanley & Co. International PLC      43,000        10/09/19      USD     262.65      USD     11,848        (13,582

GlaxoSmithKline PLC

   Citibank N.A.      100,700        11/13/19      GBP     16.70      GBP     1,755        (119,517

AMC Entertainment Holdings, Inc.

   JPMorgan Chase Bank N.A.      670,000        10/03/19      AUD     15.41      AUD     9,554         

Ansell Ltd.

   UBS AG      43,400        10/03/19      AUD     28.28      AUD     1,190        (1,241

Kone OYJ, Class B

   Credit Suisse International      34,600        10/03/19      EUR     51.92      EUR     1,806        (33,403

Novo Nordisk A/S, Class B

   UBS AG      27,000        10/03/19      DKK     350.24      DKK     9,557        (24,619

Sonic Healthcare Ltd.

   JPMorgan Chase Bank N.A.      95,000        10/03/19      AUD     28.75      AUD     2,669        (3,458

TELUS Corp.

   Goldman Sachs International      68,800        10/08/19      CAD     47.91      CAD     3,242        (6,452

Rogers Communications, Inc., Class B

   Credit Suisse International      11,100        10/10/19      CAD     66.41      CAD     716        (1,635

Rogers Communications, Inc., Class B

   Goldman Sachs International      24,900        10/10/19      CAD     65.95      CAD     1,607        (5,204

British American Tobacco PLC

   Goldman Sachs International      53,700        10/15/19      GBP     29.92      GBP     1,613        (41,829

Cie Financiere Richemont SA, Registered Shares

   Goldman Sachs International      27,500        10/15/19      CHF     79.17      CHF     2,011        (2,879

Svenska Handelsbanken AB, Class A

   Morgan Stanley & Co. International PLC      19,400        10/15/19      SEK     89.24      SEK     1,787        (6,609

AMC Entertainment Holdings, Inc.

   Morgan Stanley & Co. International PLC      379,000        10/16/19      AUD     14.35      AUD     5,405        (56,465

BAE Systems PLC

   UBS AG      193,400        10/16/19      GBP     5.60      GBP     1,102        (38,696

DBS Group Holdings Ltd.

   JPMorgan Chase Bank N.A.      169,500        10/16/19      SGD     24.72      SGD     4,238        (62,769

Imperial Brands PLC

   UBS AG      86,200        10/16/19      GBP     21.90      GBP     1,574        (21

Novo Nordisk A/S, Class B

   Goldman Sachs International      25,000        10/16/19      DKK     367.58      DKK     8,850        (7,630

RELX PLC

   Goldman Sachs International      93,100        10/16/19      EUR     22.28      EUR     2,031        (18,221

Sonic Healthcare Ltd.

   Morgan Stanley & Co. International PLC      90,000        10/16/19      AUD     29.14      AUD     2,528        (7,471

United Overseas Bank Ltd.

   JPMorgan Chase Bank N.A.      40,900        10/16/19      SGD     25.32      SGD     1,051        (16,210

Ansell Ltd.

   UBS AG      45,900        10/17/19      AUD     27.55      AUD     1,259        (15,519

AstraZeneca PLC

   UBS AG      40,500        10/17/19      GBP     76.34      GBP     2,941        (15,941

Koninklijke Philips NV

   UBS AG      40,000        10/17/19      EUR     43.62      EUR     1,696        (20,310

Schneider Electric SE

   Morgan Stanley & Co. International PLC      58,200        10/17/19      EUR     76.55      EUR     4,669        (260,937

TELUS Corp.

   UBS AG      51,300        10/18/19      CAD     47.80      CAD     2,417        (12,764

Ansell Ltd.

   Morgan Stanley & Co. International PLC      58,000        10/22/19      AUD     28.17      AUD     1,591        (12,433

Diageo PLC

   Goldman Sachs International      20,600        10/22/19      GBP     34.98      GBP     684        (3,319

Sanofi

   Goldman Sachs International      33,800        10/22/19      EUR     82.81      EUR     2,873        (110,009

 

 

        3  


Schedule of Investments  (unaudited) (continued)

September 30, 2019

  

BlackRock Enhanced International Dividend Trust (BGY)

 

OTC Options Written (continued)

 

Description    Counterparty    Number of
Contracts
     Expiration
Date
     Exercise
Price
     Notional
Amount (000)
     Value  
Call (continued)  

BAE Systems PLC

   Goldman Sachs International      270,300        10/23/19      GBP     5.69      GBP     1,541      $ (26,763

AMC Entertainment Holdings, Inc.

   JPMorgan Chase Bank N.A.      403,800        10/23/19      AUD     14.95      AUD     5,758        (20,288

GlaxoSmithKline PLC

   UBS AG      286,000        10/23/19      GBP     17.71      GBP     4,985        (71,035

Koninklijke Philips NV

   Goldman Sachs International      34,600        10/23/19      EUR     43.84      EUR     1,467        (18,641

Nestle SA, Registered Shares

   Goldman Sachs International      85,400        10/23/19      CHF     113.12      CHF     9,244        (41,125

Nestle SA, Registered Shares

   UBS AG      49,100        10/23/19      CHF     111.08      CHF     5,315        (38,910

Sanofi

   UBS AG      29,050        10/23/19      EUR     80.97      EUR     2,469        (142,019

Schneider Electric SE

   Morgan Stanley & Co. International PLC      7,700        10/23/19      EUR     78.44      EUR     618        (24,288

Schneider Electric SE

   Morgan Stanley & Co. International PLC      25,700        10/23/19      EUR     82.51      EUR     2,062        (21,183

TELUS Corp.

   Royal Bank of Canada      115,300        10/23/19      CAD     48.46      CAD     5,433        (18,771

Taiwan Semiconductor Manufacturing Co. Ltd.

   Morgan Stanley & Co. International PLC      514,000        10/23/19      USD     268.77      USD     4,565        (112,520

Diageo PLC

   Morgan Stanley & Co. International PLC      74,000        10/29/19      GBP     34.30      GBP     2,458        (36,086

GlaxoSmithKline PLC

   Credit Suisse International      172,100        10/29/19      GBP     16.72      GBP     3,000        (181,919

Kone OYJ, Class B

   Morgan Stanley & Co. International PLC      65,200        10/29/19      EUR     53.21      EUR     3,404        (83,894

RELX PLC

   UBS AG      69,000        10/29/19      EUR     21.51      EUR     1,505        (50,807

Sonic Healthcare Ltd.

   JPMorgan Chase Bank N.A.      120,100        10/29/19      AUD     28.48      AUD     3,374        (37,533

Unilever PLC

   UBS AG      53,700        10/29/19      GBP     50.25      GBP     2,625        (35,866

TELUS Corp.

   Goldman Sachs International      114,200        10/30/19      CAD     48.44      CAD     5,381        (23,027

Ansell Ltd.

   Morgan Stanley & Co. International PLC      52,600        11/01/19      AUD     28.78      AUD     1,443        (8,707

AstraZeneca PLC

   UBS AG      10,300        11/01/19      GBP     70.08      GBP     748        (47,984

BAE Systems PLC

   Morgan Stanley & Co. International PLC      406,900        11/01/19      GBP     5.79      GBP     2,319        (35,662

British American Tobacco PLC

   UBS AG      166,000        11/01/19      GBP     30.06      GBP     4,987        (181,192

Cie Financiere Richemont SA, Registered Shares

   Morgan Stanley & Co. International PLC      27,500        11/01/19      CHF     81.39      CHF     2,011        (5,798

Deutsche Post AG, Registered Shares

   Morgan Stanley & Co. International PLC      81,600        11/01/19      EUR     31.77      EUR     2,495        (25,580

Heineken NV

   UBS AG      16,600        11/01/19      EUR     98.16      EUR     1,645        (50,534

Imperial Brands PLC

   UBS AG      8,700        11/01/19      GBP     22.57      GBP     159        (12

Novartis AG, Registered Shares

   UBS AG      82,600        11/01/19      CHF     89.61      CHF     7,155        (54,517

Novo Nordisk A/S, Class B

   UBS AG      56,800        11/01/19      DKK     342.32      DKK     20,106        (152,405

SGS SA, Registered Shares

   Morgan Stanley & Co. International PLC      1,000        11/01/19      CHF     2,537.92      CHF     2,474        (23,919

Svenska Handelsbanken AB, Class A

   Morgan Stanley & Co. International PLC      262,700        11/01/19      SEK     94.21      SEK     24,192        (40,560

United Overseas Bank Ltd.

   JPMorgan Chase Bank N.A.      117,700        11/01/19      SGD     26.76      SGD     3,024        (10,558

Deutsche Post AG, Registered Shares

   Morgan Stanley & Co. International PLC      193,900        11/05/19      EUR     30.81      EUR     5,928        (147,618

Ansell Ltd.

   Morgan Stanley & Co. International PLC      45,900        11/06/19      AUD     28.17      AUD     1,259        (14,789

BAE Systems PLC

   Morgan Stanley & Co. International PLC      217,600        11/06/19      GBP     5.91      GBP     1,240        (14,512

British American Tobacco PLC

   Citibank N.A.      74,600        11/06/19      GBP     30.48      GBP     2,241        (72,970

Diageo PLC

   Morgan Stanley & Co. International PLC      86,100        11/06/19      GBP     33.24      GBP     2,860        (101,874

SGS SA, Registered Shares

   Credit Suisse International      1,100        11/06/19      CHF     2,553.06      CHF     2,721        (24,598

Sanofi

   Citibank N.A.      29,100        11/06/19      EUR     81.42      EUR     2,473        (142,835

Sonic Healthcare Ltd.

   Morgan Stanley & Co. International PLC      89,000        11/06/19      AUD     28.60      AUD     2,500        (29,061

TELUS Corp.

   Goldman Sachs International      67,900        11/06/19      CAD     48.82      CAD     3,199        (12,857

United Overseas Bank Ltd.

   BNP Paribas S.A.      112,000        11/06/19      SGD     26.15      SGD     2,877        (24,773

DBS Group Holdings Ltd.

   JPMorgan Chase Bank N.A.      121,000        11/07/19      SGD     25.04      SGD     3,025        (45,063

Rogers Communications, Inc., Class B

   Citibank N.A.      46,800        11/07/19      CAD     67.69      CAD     3,020        (14,199

 

 

4      


Schedule of Investments  (unaudited) (continued)

September 30, 2019

  

BlackRock Enhanced International Dividend Trust (BGY)

 

OTC Options Written (continued)

 

Description   Counterparty    Number of
Contracts
     Expiration
Date
     Exercise
Price
     Notional
Amount (000)
     Value  
Call (continued)  

Imperial Brands PLC

  UBS AG      294,900        11/12/19      GBP      21.99      GBP      5,385      $ (10,594

Kone OYJ, Class B

  Citibank N.A.      42,100        11/12/19      EUR      53.01      EUR      2,198        (69,919

RELX PLC

  Morgan Stanley & Co. International PLC      40,700        11/12/19      EUR      21.61      EUR      888        (31,630

Unilever PLC

  UBS AG      137,000        11/12/19      GBP      49.94      GBP      6,697        (119,531

Ansell Ltd.

  Goldman Sachs International      43,400        11/13/19      AUD      28.90      AUD      1,190        (9,069

BAE Systems PLC

  Morgan Stanley & Co. International PLC      218,000        11/13/19      GBP      5.91      GBP      1,243        (15,718

Deutsche Post AG, Registered Shares

  UBS AG      144,000        11/13/19      EUR      30.29      EUR      4,402        (160,963

Heineken NV

  Morgan Stanley & Co. International PLC      58,600        11/13/19      EUR      98.70      EUR      5,807        (184,125

Koninklijke Philips NV

  Morgan Stanley & Co. International PLC      128,300        11/13/19      EUR      44.59      EUR      5,440        (91,734

Novartis AG, Registered Shares

  UBS AG      53,400        11/13/19      CHF      87.02      CHF      4,626        (100,065

Novo Nordisk A/S, Class B

  Morgan Stanley & Co. International PLC      17,100        11/13/19      DKK      356.12      DKK      6,053        (30,816

Schneider Electric SE

  Goldman Sachs International      18,500        11/14/19      EUR      79.87      EUR      1,484        (57,026

TELUS Corp.

  Goldman Sachs International      76,100        11/15/19      CAD      48.85      CAD      3,586        (18,077

Svenska Handelsbanken AB, Class A

  Morgan Stanley & Co. International PLC      262,700        11/19/19      SEK      90.88      SEK      24,192        (100,370

Taiwan Semiconductor Manufacturing Co. Ltd.

  Citibank N.A.      131,000        11/19/19      USD      268.98      USD      1,163        (38,197

Sanofi

  Credit Suisse International      33,800        11/21/19      EUR      87.81      EUR      2,873        (50,228

Rogers Communications, Inc., Class B

  Morgan Stanley & Co. International PLC      36,100        11/25/19      CAD      66.20      CAD      2,330        (31,030

Novo Nordisk A/S, Class B

  Morgan Stanley & Co. International PLC      41,000        11/26/19      DKK      370.03      DKK      14,513        (44,006
                      

 

 

 
   $ (4,436,952
  

 

 

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of investments and derivative financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 — Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that the Trust has the ability to access

 

   

Level 2 — Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market-corroborated inputs)

 

   

Level 3 — Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Trust’s own assumptions used in determining the fair value of investments and derivative financial instruments)

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by privately held companies or funds. There may not be a secondary market, and/or there are a limited number of investors. The categorization of a value determined for investments and derivative financial instruments is based on the pricing transparency of the investments and derivative financial instruments and is not necessarily an indication of the risks associated with investing in those securities. For information about the Trust’s policy regarding valuation of investments and derivative financial instruments, refer to the Trust’s most recent financial statements as contained in its semi-annual report.

 

 

        5  


Schedule of Investments  (unaudited) (continued)

September 30, 2019

  

BlackRock Enhanced International Dividend Trust (BGY)

 

The following tables summarize the Trust’s investments and derivative financial instruments categorized in the disclosure hierarchy:

 

      Level 1        Level 2        Level 3        Total  

Assets:

 

Investments:

 

Common Stocks:

 

Australia

   $        $ 60,654,211        $        $ 60,654,211  

Canada

     79,229,435                            79,229,435  

Denmark

              19,161,311                   19,161,311  

Finland

              17,933,367                   17,933,367  

France

              47,242,536                   47,242,536  

Germany

              31,062,524                   31,062,524  

India

              9,881,189          1,345,352          11,226,541  

Netherlands

              35,610,912                   35,610,912  

Singapore

              29,378,167                   29,378,167  

Sweden

              17,912,995                   17,912,995  

Switzerland

              73,365,052                   73,365,052  

Taiwan

              13,579,857                   13,579,857  

United Kingdom

              169,235,231                   169,235,231  

United States

     17,916,805                            17,916,805  

Preferred Stock

                       3,911,424          3,911,424  

Short-Term Securities

     6,083,252                            6,083,252  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 103,229,492        $ 525,017,352        $ 5,256,776        $ 633,503,620  
  

 

 

      

 

 

      

 

 

      

 

 

 
Derivative Financial Instruments(a)                  

Liabilities:

 

Equity contracts

   $ (69,253      $ (4,436,952      $        $ (4,506,205
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a)

Derivative financial instruments are options written. Options written are shown at value.

 

 

 

6